Association of frailty with dementia and the impact of frailty on antihypertensive treatment protection against dementia in older hypertensive adults
Assoziation von Frailty mit Demenz und Einfluss von Frailty auf den Schutz einer antihypertensiven Behandlung vor Demenz bei älteren hypertensiven Erwachsenen
Age and Ageing · 01.02.2026 · 55 (2)
DOI: 10.1093/ageing/afag037 ↗Auf einen Blick
Bei 4.692 älteren Menschen mit isolierter systolischer Hypertonie war ein höherer Frailty-Index mit mehr Demenz verbunden. Der Nutzen einer antihypertensiven Behandlung gegen Demenz war bei niedriger Frailty am deutlichsten.
Fragestellung
Ist Frailty bei älteren Menschen mit Hypertonie mit Demenz assoziiert, und beeinflusst Frailty die Wirksamkeit einer antihypertensiven Behandlung zur Demenzprävention?
Methode
Analyse von Daten aus der Systolic Hypertension in the Elderly Program trial; Frailty-Index mit 55 Gesundheitsdefiziten; multinomiale Regressionsmodelle zur Assoziation von Frailty, Demenz und Behandlungswirkung.
Ergebnisse
4692 Teilnehmende, mittleres Alter 72,1 Jahre, 56,8 % Frauen. 81 Demenzfälle. Pro SD-Anstieg des FI war das Demenzrisiko höher (OR 1,33; 95 %-KI 1,08–1,64).
Schlussfolgerung der Autor:innen
Bei isolierter systolischer Hypertonie könnte Frailty ein Risikofaktor für Demenz sein, und höhere Frailty könnte die Wirksamkeit einer antihypertensiven Behandlung zur Senkung des Demenzrisikos abschwächen.
Kernaussagen
- Pro SD-Anstieg des FI: OR 1,33; 95 %-KI 1,08–1,64
- Zusammenhang in der aktiven Behandlungsgruppe stärker als unter Placebo
- Antihypertensive Behandlung senkte das Demenzrisiko nur im niedrigsten FI-Quartil
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Fachartikel in der Zeitschrift Age and Ageing, online erschienen am 25.02.2026. Verfasst von Linan Chen und 14 weiteren Autor:innen. Beteiligte Einrichtung: The George Institute for Global Health, University of New South Wales Faculty of Medicine, Sydney, New South Wales, Australia. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, NHLBI NIH HHS, University of New South Wales.
Themen: Demenz, Gerontologische Pflege
Abstract (Originalsprache)
Background
The relationship between frailty and dementia risk in hypertensive patients remains unclear, as does the impact of frailty on the effectiveness of antihypertensive treatment in preventing dementia.
Methods
Using data from the Systolic Hypertension in the Elderly Program trial, a baseline frailty index (FI) including 55 health deficits was constructed. Multinomial regression models were used to examine the association between frailty and dementia, as well as to examine whether the impact of antihypertensive treatment on the risk of dementia was modified by baseline FI.
Results
A total of 4692 participants (mean age: 72.1 years, 56.8% female) were included with a median (inter-quartile interval) FI of 0.127 (0.091–0.173). During a median follow-up of 4.4 years, 81 dementia cases occurred. Each SD (0.061) increase in FI was associated with a 33% higher risk of dementia [odds ratio (OR): 1.33, 95% confidence interval (CI): 1.08–1.64], after adjusting for age, sex, race, education and treatment group. This association differed between the active treatment group (OR: 1.57; 95% CI: 1.16–2.11) and the placebo group (OR: 1.17; 95% CI: 0.87–1.56), with a P for interaction = .049. Correspondingly, in the lowest FI quarter, antihypertensive treatment reduced dementia risk (OR: 0.19, 95% CI: 0.04–0.94), an effect not observed in higher FI quarters (interaction P = .058).
Conclusion
In patients with isolated systolic hypertension, frailty may serve as a risk factor for dementia, and elevated levels of frailty may attenuate the effectiveness of antihypertensive treatment in reducing dementia risk.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The George Institute for Global Health, University of New South Wales Faculty of Medicine, Sydney, New South Wales, Australia.
- Department of Neurology and Clinical Research Center of Neurological Disease, Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China.
- Division of Neurology, Dalhousie University Department of Medicine, Halifax, Nova Scotia, Canada.
- Division of Geriatric Medicine, Dalhousie University Department of Medicine, Halifax, Nova Scotia, Canada.
- Frailty and Elder Care Network, Halifax, Nova Scotia, Canada.
- Australian Frailty Network, Centre for Health Services Research, The University of Queensland Faculty of Health and Behavioural Sciences, Brisbane, Queensland, Australia.
ORCID-Profile: Linan Chen, Kenneth Rockwood, David D Ward, Ruth E Hubbard, Mark Woodward, Oisin Fitzgerald, Katie Harris
Förderung
- NIA NIH HHS
- NHLBI NIH HHS
- University of New South Wales
- National Institute on Aging
- National Heart, Lung, and Blood Institute
Zitieren
APA
Chen, L., You, S., Ee, N., Rockwood, K., Ward, D. D., Hubbard, R. E., Woodward, M., Fitzgerald, O., Wang, R., Gao, Y., Williamson, J. D., Anderson, C. S., Harris, K., Chen, X., & Peters, R. (2026). Association of frailty with dementia and the impact of frailty on antihypertensive treatment protection against dementia in older hypertensive adults. Age and Ageing, 55(2). https://doi.org/10.1093/ageing/afag037
Vancouver
Chen L, You S, Ee N, Rockwood K, Ward DD, Hubbard RE, et al. Association of frailty with dementia and the impact of frailty on antihypertensive treatment protection against dementia in older hypertensive adults. Age and Ageing. 2026;55(2). doi:10.1093/ageing/afag037
BibTeX
@article{Chen2026,
author = {Chen, Linan and You, Shoujiang and Ee, Nicole and Rockwood, Kenneth and Ward, David D and Hubbard, Ruth E and Woodward, Mark and Fitzgerald, Oisin and Wang, Ruirui and Gao, Yijie and Williamson, Jeff D and Anderson, Craig S and Harris, Katie and Chen, Xiaoying and Peters, Ruth},
title = {Association of frailty with dementia and the impact of frailty on antihypertensive treatment protection against dementia in older hypertensive adults},
journal = {Age and Ageing},
year = {2026},
volume = {55},
number = {2},
doi = {10.1093/ageing/afag037}
}
EUVIMED